Cameco Sells Uranium at $67.79 a Pound While the Spot Price Sits at $86
Hypothesis Opus 5 · Research Opus 5 · Writing Opus 5 · Prompt v1.5
Uranium itself has barely moved since February — spot was $86.36 a pound in late July, and the long-term contract price has been stuck at an 18-year-high $94 since June. Yet the companies that mine and enrich it rose 11% to 27% over the past month. What moved was contracts and policy, not the metal, and neither of the two protagonists with real revenue is earning the headline price.
Cameco delivered uranium at US$67.79 a pound last quarter, roughly 22% below spot, off a book written years ago; its gross margin fell to 21.1% from 29.3%. Centrus nearly doubled its backlog to $4.5bn stretching to 2040, but realized enrichment prices rose only 3% on 23% lower volumes, and operating income fell 69%. Cameco is the odd one: down 18% over six months and dearer for it, at 64.6x forward earnings against about 56x in May. NexGen and UEC have no earnings to anchor.
| Ticker | Company | Segment | Trend · 13mo | 30D | 1Y |
|---|---|---|---|---|---|
| The subject · what this brief is about | |||||
CCJ | Cameco | Uranium | ⚠️ Emerging Bear | +10.3% | +39.8% |
LEU | Centrus Energy | Uranium | ⚠️ Emerging Bear | +2.6% | +0.9% |
NXE | NexGen Energy | Uranium | ⚠️ Emerging Bear | +12.3% | +60.9% |
| Compared against · context, not the story | |||||
UEC | Uranium Energy | Uranium | ⚠️ Emerging Bear | +22.5% | +23.9% |
BWXT | BWX Technologies | Naval & Shipbuilding | ⚠️ Emerging Bear | −10.2% | −4.6% |
URA | Global X - Uranium ETF | Asset Management | ⚠️ Emerging Bear | +10.5% | +27.6% |
URNM | Sprott Uranium Miners ETF | Asset Management | ⚠️ Emerging Bear | +11.6% | +30.6% |
OKLO | Oklo | Emerging & Specialized Energy | 🔴 Cont. Bear | −6.4% | −38.0% |
SMR | NuScale Power | Advanced Nuclear | 🔴 Cont. Bear | +7.3% | −72.2% |
DNN | Denison Mines | Uranium | ⚠️ Emerging Bear | +10.7% | +73.1% |
UUUU | Energy Fuels | Uranium | ⚠️ Emerging Bear | +12.9% | +47.9% |
12-month price & trend
| Ticker | Mkt cap | P/E | P/E fwd | P/S | P/S fwd | P/GP | P/GP fwd | EV/EBITDA | FCF yld |
|---|---|---|---|---|---|---|---|---|---|
CCJ | $43.4B | 168.1x | 64.6x | 17.2x | 12.1x | 62.5x | 44.0x | 69.3x | 0.8% |
LEU | $3.4B | 71.6x | 72.0x | 7.2x | 7.3x | 30.9x | 31.4x | 37.4x | -6.5% |
NXE | $7.0B | n/m | — | n/m | — | — | — | n/m | -2.5% |
| Ticker | Mkt cap | P/E | P/E fwd | P/S | P/S fwd | P/GP | P/GP fwd | EV/EBITDA | FCF yld |
|---|---|---|---|---|---|---|---|---|---|
UEC | $5.5B | n/m | — | 274.6x | 55.3x | 648.9x | 130.6x | n/m | -2.2% |
BWXT | $14.7B | 41.2x | 33.7x | 4.2x | 3.9x | 18.9x | 17.5x | 29.0x | 2.2% |
URA | $3.9B | — | — | — | — | — | — | — | — |
| Ticker | Mkt cap | P/E | P/E fwd | P/S | P/S fwd | P/GP | P/GP fwd | EV/EBITDA | FCF yld |
|---|---|---|---|---|---|---|---|---|---|
URNM | $1.1B | — | — | — | — | — | — | — | — |
OKLO | $7.2B | n/m | — | — | — | — | — | n/m | -3.8% |
SMR | $2.8B | n/m | — | 261.9x | 91.1x | — | 432.7x | n/m | -27.7% |
| Ticker | Mkt cap | P/E | P/E fwd | P/S | P/S fwd | P/GP | P/GP fwd | EV/EBITDA | FCF yld |
|---|---|---|---|---|---|---|---|---|---|
DNN | $2.9B | n/m | — | 988.4x | 120.1x | — | — | n/m | -4.1% |
UUUU | $3.7B | n/m | — | 35.0x | 25.0x | 80.8x | 57.9x | n/m | -3.0% |
Consensus projections
| Ticker | FY2026E | FY2027E | FY2028E | |
|---|---|---|---|---|
CCJ | Revenue | +4.5% | +10.7% | +6.8% |
| EPS | +7.6% | +70.8% | +25.1% | |
LEU | Revenue | +4.3% | +1.0% | −10.1% |
| EPS | −44.3% | +14.9% | −15.1% | |
NXE | Revenue | −68.7% | +131.4% | +32282.1% |
| EPS | −38.6% | −10.8% | +37.8% | |
UEC | Revenue | −59.3% | +272.6% | +157.9% |
| EPS | +58.7% | −79.8% | −647.6% | |
BWXT | Revenue | +20.6% | +9.6% | +7.4% |
| EPS | +24.1% | +11.1% | +11.9% | |
OKLO | Revenue | — | +247.3% | +577.4% |
| EPS | +50.0% | +10.3% | +16.5% | |
SMR | Revenue | −26.7% | +434.9% | +101.2% |
| EPS | −74.7% | +33.4% | −18.3% | |
DNN | Revenue | +394.2% | −27.3% | +1699.7% |
| EPS | −30.5% | −73.1% | −363.0% | |
UUUU | Revenue | +152.8% | +63.3% | +59.0% |
| EPS | −52.3% | −188.4% | +252.4% |
Forward fiscal years only. Blank means no analyst coverage for that year.
The price everyone quotes is not the price anyone earns
Cameco, the Saskatoon miner that also owns 49% of the reactor builder Westinghouse, sold its uranium last quarter at an average of US$67.79 a pound. The published spot price at the end of July was $86.36, and the price utilities pay under new long-term contracts has sat at $94 since June, the highest in 18 years. Cameco's realized price was up 18% from a year earlier and still 28% below that contract number, because deliveries come off a book signed when uranium was cheap.
That gap is the story of the whole nuclear fuel chain right now. The headline prices are at decade highs; the profit-and-loss statements are not. Over the past month shares in the fuel names rose together — Cameco 11.5%, the enricher Centrus 14.3%, the developers NexGen 21.5% and Uranium Energy Corp 26.8% — while the metal did nothing at all. Strip each name's two best sessions, clustered on a handful of shared news dates in late July and early August, and the month's gain becomes a loss. This was an event, not a re-rating.
What actually re-contracted
The events were real. Centrus, a Bethesda, Maryland company that sells separative work units — the measure of enrichment effort, or SWU — and no mined ore, disclosed a backlog of $4.5bn extending through 2040, against $2.3bn of commercial backlog three months earlier. Of that, $2.4bn of enrichment work is now under definitive agreements rather than contingent ones. It signed a firm high-assay low-enriched uranium off-take with the reactor developer X-energy and a letter of intent with Oklo to fuel up to five units from 2029, both carrying prepayments. Separately, the Department of Energy conditionally committed $17.5bn of loans on 23 June for long-lead equipment for up to ten Westinghouse AP1000 reactors, and Cameco disclosed that Westinghouse had confidentially filed for an initial public offering.
The mechanism underneath is a deadline. US reactor operators bought about 3.28 million SWU of Russian enrichment in 2025, nearly 26% of their purchases, and the waiver authority that permits it expires no later than January 2028. Urenco is adding roughly 700,000 SWU a year in New Mexico by early 2027, only a partial replacement. That shortfall is why enrichment quotes are elevated — SWU prices rose about 11% last year to $108.70 a unit.
Two income statements going the wrong way
Centrus is not capturing it yet. Enrichment-segment revenue rose 22% to $153.4m, but volumes fell 23% and realized SWU pricing rose 3% while unit costs rose 13%. Gross margin compressed to 28.3% from 34.9%, and operating income fell 69% to $10.4m. Consensus has 2026 earnings per share at $2.50, down 44% from last year. Management itself says utilities remain in wait-and-see mode until it demonstrates centrifuge installation. The balance sheet is improving — $1.9bn of cash, commercial Piketon production pulled forward to 2029 — while the earnings line deteriorates.
Cameco's quarter was worse on the surface and better underneath. Revenue of $814.1m fell 7.2%, gross margin dropped to 21.1% from 29.3%, and net income fell 92% to $25.2m, largely because its share of Westinghouse EBITDA halved to $163m against a prior year containing a one-off payment on the Czech Dukovany project. Production guidance of 19.5–21.5 million pounds held through weather disruptions at Key Lake and McArthur River and a Cigar Lake suspension after quarter-end. Its fuel-services realized price rose 13% to C$41.67 per kilogram of uranium. New contracts now carry floors in the high-$70s and ceilings near $160.
The valuation is the uncomfortable part. Cameco has fallen 17.9% in six months and become more expensive doing it: price per dollar of trailing gross profit has gone from roughly 33x a year ago to about 45x, because gross profit fell faster than the shares. Forward earnings multiple is 64.6x, up from roughly 56x in May, resting on a projected jump to $2.64 of 2027 earnings per share from $1.54 this year.
The controls
NexGen, a pre-revenue developer whose Rook I project sits in Saskatchewan's Athabasca Basin, trades at 5.27x book on a $7.02bn market value with first pounds around 2030 and financing for a C$2.2bn build not yet closed. It has 11.3 million pounds contracted, all spot-indexed, and deliberately leaves 96% of reserves uncommitted — the mirror image of Cameco's floors-and-ceilings book. Uranium Energy Corp, a Texas-based in-situ recovery producer, is guided to fiscal 2026 revenue of $26.9m, down 59%, with an $85.5m loss. Their outsized monthly gains are leverage to a metal that did not move.
One name went the other way: BWX Technologies, which builds naval reactors, fell 10.2% over the same month. Whatever lifted the fuel names, it was not indiscriminate enthusiasm for nuclear.
The setup
Where it stands — Backlogs and policy are re-contracting the Western fuel chain; realized prices and margins at both revenue-generating companies are still falling. Would confirm — Cameco's realized uranium price closing on spot in coming quarters, or Centrus posting SWU pricing gains above 10%. Would invalidate — Centrus funding Piketon through further equity sales without new priced volume, or Cameco cutting its 19.5–21.5m lb guidance. Watch next — Westinghouse's public IPO filing, and the January 2028 expiry of Russian enrichment import waivers. Valuation — Cameco 168.1x trailing and 64.6x forward earnings versus about 56x forward in May; Centrus 71.6x trailing against 72.0x forward.












